While hot-button health care issues such as abortion and the Affordable Care Act roil the presidential race, Democrats and Republicans in statehouses around the country have been quietly working together to tackle the nation’s medical debt crisis. New laws to curb aggressive hospital billing, to expand charity care for lower-income patients, and to rein in…
Justin Schrager is the CMO of Vital.io. Their technology sits in the hospital telling patients what is going on with their care while they are in the hospital, particularly in the ER. Justin showed a deep demo about the patient experience of using Vital.io which includes what the patient can expect and guides them through…
This analysis finds that Medicare’s negotiated prices for 10 high-expenditure prescription drugs are lower than what private Medicare drug plans had been paying, but still much higher than the prices available in 11 other wealthy nations.. It is available on the Peterson-KFF Health System Tracker.
CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care by tying payments to patient outcomes and encouraging tech-enabled, preventive care. Experts say it could benefit digitally mature, value-focused providers first, but its overall success will hinge on clear metrics, better data sharing and sustained participation….
This responsibility goes beyond mere box-ticking; it requires a deep, introspective examination of our own biases and blind spots and a genuine commitment to putting the well-being of the communities we serve first. The post In the Pharmaceutical Industry, Ethics are Still More Valuable Than AI appeared first on MedCity News.
The distinction between value-based care and value-based payment isn’t merely semantic — it represents a crucial fork in the road for healthcare delivery. As AI and other technologies become more prevalent in healthcare, we must ensure they’re deployed in service of improving patient care rather than merely optimizing revenue. The post The Dark Side of…
The American Association of Public Opinion Research (AAPOR) recognized KFF’s Mollyann Brodie, Ph.D., with the AAPOR Award for Distinguished Achievement for her outstanding leadership and contributions to the field of public opinion research over three decades. Also, KFF’s Surveys of Immigrants received the 2026 AAPOR Inclusive Voices Award, which recognizes work examining complex challenges related…
This resource chronologically lists and briefly describes key actions taken by the Trump Administration through the Department of Health and Human Services (HHS) that affect public health in the U.S. The actions are listed in the order in which they were first issued, reported or announced.
Structure Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to an average 16% weight loss measured at 44 weeks. Based on these results, the biotech is preparing for Phase 3 testing expected to begin in the second half of this year. The post Structure Therapeutics Oral GLP-1 Obesity Drug Achieves ‘Injectable-Like Efficacy’ in Phase 2…
Virtual solutions for depression and anxiety can lead to clinically meaningful outcomes, but certain pricing models may increase costs for employers and health plans, according to the Peterson Health Technology Institute. The post PHTI: Digital Mental Health Solutions Work, But Can Be Costly appeared first on MedCity News.